Pharma Company that Raised Price of EpiPen by 600% Accused of Overcharging Gov’t – Benjamin Dixon Show

Mylan, the pharmaceutical company that produces EpiPens, has been accused of overcharging the government by labeling their drug as generic at the state level, increasing their revenue from $86 million to $487 million. Benjamin Dixon discusses this in the video below.